Answers are grounded in this paper and cite their sources.
Truncated abstract precludes conclusions; leaves open dual antiplatelet therapy benefit in TIA and minor stroke.
Some patients with stroke and transient ischemic attack (TIA) of the brain are at high risk for early recurrent stroke, usually due to arterial thromboembolism.1,2 Aspirin reduces the risk of early recurrent stroke by only 12% (95% confidence interval [CI], 3 to 20).3 Adding clopidogrel to aspirin in patients with acute coronary syndromes reduces the risk of recurrent vascular events by 20% (95% CI, 10 to 28) but increases the risk of major bleeding by 38% (95% CI, 13 to 67).4 For patients with acute ischemic stroke, who are prone to early spontaneous hemorrhagic transformation of infarcted brain, adding . . .
No takes yet. Share an insight, caveat, or question.
Graeme J. Hankey (2013) studied Acute transient ischemic attack and minor stroke. Dual antiplatelet therapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: